{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:25:08Z","timestamp":1762521908798},"reference-count":37,"publisher":"Baishideng Publishing Group Inc.","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i22.5285","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T11:53:57Z","timestamp":1465559637000},"page":"5285","source":"Crossref","is-referenced-by-count":11,"title":["Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options"],"prefix":"10.3748","volume":"22","author":[{"given":"Javier","family":"Ampuero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7085"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.960396"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2015.06.009"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ampuero J, Romero-Gómez M, Reddy KR. Review article: HCV genotype 3 - the new treatment challenge. Aliment Pharmacol Ther 2014;39:686-698.","DOI":"10.1111\/apt.12646"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0844-y"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01481"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27095"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.09.009"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310421"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31.","DOI":"10.1186\/1471-2288-6-31"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.","DOI":"10.1186\/1471-2288-3-25"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2015.07.009"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1385929"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i11.2902"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.043"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.007"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.001"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214853"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7734"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.826189"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13264"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S36247"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27726"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Foster GR, McLauchlan J, Irving W, Cheung M, Hudson B, Verma S, Agarwal K, HCV Research UK EAP Group. Treatment of decompensated HCV cirrhosis in patients with diverse genotypes: 12 weeks sofosbuvir and NS5A inhibitors with\/without ribavirin is effective in HCV genotypes 1 and 3. J Hepatol 2015;62:S190-S191.","DOI":"10.1016\/S0168-8278(15)30009-X"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Welzel TM, Herzer K, Ferenci P, Petersen J, Gschwantler M, Cornberg M, Berg T, Spengler U, Weiland O, Van der Valk M. Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program. J Hepatol 2015;62:S620.","DOI":"10.1016\/S0168-8278(15)30975-2"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.063"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02193-12"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Alqahtani S, Zeuzem S, Manns M, Kuo A, Di Bisceglie AM, Reddy R, Mailliard M, O’Leary J, Pockros P, Kwo PY. Safety and effectiveness of sofosbuvir-based regimens for the treatment of hepatitis C genotype 3 and 4 infections: Interim analysis of a prospective, observational study. J Hepatol 2015;62:S652.","DOI":"10.1016\/S0168-8278(15)31042-4"},{"key":"ref32","unstructured":"Chulanov V, Zhdanov K, Kersey K, Zhu Y, Massetto B, Zhuravel S. Sofosbuvir plus ribavirin for the treatment of Russian patients with chronic HCV genotype 1 or 3 infection. Hepatology 2014;1:676A."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Dalgard O, Weis N, Noraberg G, Isaksen K, Oevrehus A, Skalshoj Skjar M, Weiland O. Sofosbuvir containing regimes to patients with HCV genotype 3 infection. A scandinavian real-life experience. J Hepatol 2015;62:S287.","DOI":"10.1016\/S0168-8278(15)30203-8"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Hezode C, Ledinghen V, Fontaine H, Zoulim F, Lebray P, Boyer N, Larrey D, Silvain C, Botta-Fridlund D, Leroy V. Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program. Hepatology 2015;62:314A.","DOI":"10.1016\/S0168-8278(15)30159-8"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ingiliz P, Christensen S, Hueppe D, Lutz T, Schewe K, Boesecke C, Simon KG, Schmutz G, Baumgarten A, Busch H. German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV\/HCV co-infected patients (GECOSO). J Hepatol 2015;62:S650.","DOI":"10.1016\/S0168-8278(15)31037-0"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316145"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i22\/5285.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T14:13:26Z","timestamp":1568038406000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i22\/5285.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":37,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i22.5285","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}